These studies are a continuation and extension of investigations initiated in the Brain Trauma Center feasibility grant, which has been active for 2 years. During this period we have successfully addressed and extended the specific aims of the initial grant and have found in humans: 1) marked upregulation of interleukin-1Beta (IL, 1Beta) in the SCF following head injury; 2) remarkable suppression of IL-1Beta in CSF under conditions of moderate hypothermia. Utilizing two rat models of traumatic brain injury (TBeta1; the Lighthall cortical confusion and weight drop) we have found: 1) A marked elevation in IL-1Beta RNA in cortical tissue, 2) A marked elevation of nerve growth factor (NGF) and NGF RNA in cortical tissue; 3) Total suppression of the elevation of NGF and NGF RNA by 4 hours of post-trauma hypothermia; 4) Suppression of the NGF response by administration of IL-1Beta receptor antagonist protein (IRAP), suggesting that IL-1Beta mediates NGF expression after trauma. Based on our findings, the proposed studies will examine IL-1Beta, NGF, and the NGF receptor, p75NGFR in the Lighthall model of rat TBeta1, and assess the therapeutic value of several intervention therapies. We will assess the effects of TBeta1 on the time course of expression of IL-1Beta RNA in the rat brain, and the effect of specific interventions on this time course; post-trauma hypothermia, administration of IRAP or interleukin-4 (IL-4) via implantation of protein-secreting transfected fibroblasts, and combination of hypothermia and either IRAP or IL-4 therapy. We will also determine the time course of expression of NGF protein and RNA and p75NGFR RNA in the cortex following cortical confusion. We will also employ the four therapeutic strategies used in the IL-1Beta studies, to determine their efforts on NGF/p75NGFR expression following TBeta1, and explore the mechanisms relating cytokine expression and NGF regulation. We will also explore the hypothesis that upregulation of NGF, following trauma, induces increased antioxidant enzyme activity by measuring the antioxidant enzymes glutathione peroxidase, glutathione reductase, catalase, and superoxide dismutase following TBeta1. Furthermore, we will examine the effect of purified NGF protein injected into the cortex and hippocampus on the production of the same antioxidant enzymes and employ the four therapeutic strategies used above to investigate the relationship among IL,-1Beta, NGF, and the induction of antioxidant enzymes. Finally, we will assess cerebral edema and lesion volume utilizing the TBeta1 model with and without the interventions outlined above. We will determine the capability of magnetic resonance imaging (MRI) to non-invasively measure these changes, comparing MRI measurements to traditional histological determinants of brain water and lesion size. This in vivo methodology should enable us to develop a model for rapid reliable assessment of TBeta1 interventions in fewer animals (each animal will be assessed at multiple time points) without the confound of interanimal variations and cohort differences. Collaborations will extend these studies of NGF and IL-1Beta to other inflammatory cascades and reactive oxygen species in secondary injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
2P50NS030318-07
Application #
6273798
Study Section
Project Start
1998-03-01
Project End
1999-02-28
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
7
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Ikonomovic, Milos D; Mi, Zhiping; Abrahamson, Eric E (2017) Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders. Ageing Res Rev 34:51-63
Osier, Nicole D; Bales, James W; Pugh, Bunny et al. (2017) Variation in PPP3CC Genotype Is Associated with Long-Term Recovery after Severe Brain Injury. J Neurotrauma 34:86-96
Jackson, Edwin K; Kotermanski, Shawn E; Menshikova, Elizabeth V et al. (2017) Adenosine production by brain cells. J Neurochem 141:676-693
Willyerd, F Anthony; Empey, Philip E; Philbrick, Ashley et al. (2016) Expression of ATP-Binding Cassette Transporters B1 and C1 after Severe Traumatic Brain Injury in Humans. J Neurotrauma 33:226-31
Janata, Andreas; Magnet, Ingrid A M; Uray, Thomas et al. (2014) Regional TNF? mapping in the brain reveals the striatum as a neuroinflammatory target after ventricular fibrillation cardiac arrest in rats. Resuscitation 85:694-701
Drabek, Tomas; Janata, Andreas; Wilson, Caleb D et al. (2014) Minocycline attenuates brain tissue levels of TNF-? produced by neurons after prolonged hypothermic cardiac arrest in rats. Resuscitation 85:284-91
Alexander, Sheila A; Ren, Dianxu; Gunn, Scott R et al. (2014) Interleukin 6 and apolipoprotein E as predictors of acute brain dysfunction and survival in critical care patients. Am J Crit Care 23:49-57
Conley, Yvette P; Okonkwo, David O; Deslouches, Sandra et al. (2014) Mitochondrial polymorphisms impact outcomes after severe traumatic brain injury. J Neurotrauma 31:34-41
Abrahamson, Eric E; Foley, Lesley M; Dekosky, Steven T et al. (2013) Cerebral blood flow changes after brain injury in human amyloid-beta knock-in mice. J Cereb Blood Flow Metab 33:826-33
Cousar, J'mir L; Conley, Yvette P; Willyerd, F Anthony et al. (2013) Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury. Neurocrit Care 19:192-8

Showing the most recent 10 out of 116 publications